probably undervalued by half...., page-2

Good article and vindicates biotech investors perception of the Australian market. To paraphrase the London Based Fund Manager quoted in the article "biotechnology sector offering some of the best growth stocks on his Australian watch list, because the Australian investor just doesn't get it". Further reinforced by Company Executives complaining that local fund managers and analysts have no idea either.

Oh well we will have to wait until a biotech Anvil hits them on the head from a very great height!